Invenio Imaging Inc.
San Jose, CA
- UEI
- N8ADGJWND191
- CAGE
- 6CBD7
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2190 Bering Dr, San Jose, CA 95131, USA
- Website
- invenio-imaging.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i topic 331: biopsy guidance with coherent raman spectroscopy | National Cancer Institute (NIH) | $205,915 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| New York University | R01CA226527 | $70,078 | |
| New York University | R01CA226527 | $34,974 | |
| New York University | R01CA226527 | $67,188 | |
| New York University | R01CA226527 | $130,318 |
Similar vendors
About the company
Invenio Imaging Inc., based in San Jose, California, develops FDA-cleared medical imaging devices combining stimulated Raman histology and artificial intelligence for rapid cancer diagnosis, operating as a federal grant recipient focused on research and development in biotechnology. The company acts as a prime recipient on National Cancer Institute (NCI) grants and as a sub-recipient on related National Institutes of Health sub-awards from New York University.
Invenio's federal footprint is concentrated in biomedical research funding. The National Cancer Institute accounts for six awards totaling $206 thousand in combined potential value, alongside additional awards from the National Science Foundation and the broader National Institutes of Health. The company's core capability centers on translating stimulated Raman histology technology for clinical applications; the representative prime grant is a March 2023 NCI project grant (ultimate completion February 2026) supporting a multicenter study combining stimulated Raman histology with deep learning for rapid lung cancer detection via bronchoscopy and on-site tissue evaluation. Invenio serves as a sub-recipient on four related New York University–led NCI sub-awards (April 2022, September 2023, January 2025, and September 2025) for clinical translation of stimulated Raman histology technology.
Activity has been sparse and episodic — two awards in 2014, one in 2016, one in 2022, two in 2023, and two in 2025 — reflecting the grant-driven rhythm of early-stage medical device research funding rather than steady federal contracting volume. The company does not hold federal contract vehicles (GWACs, IDIQs, or BPAs) and has not won federal contracts as a prime. Combined potential value across all eleven awards is $206 thousand, though obligated dollars total $7.9 million, indicating that the grant awards carry significantly higher realized funding than their initial potential-value ceilings reflect. Invenio's federal engagement is narrowly focused on NCI-sponsored translational research for cancer detection and diagnosis, with no presence in procurement or service contracting.
Quick answers
Is Invenio Imaging Inc. registered in SAM.gov?
Yes. Invenio Imaging Inc.'s SAM.gov registration is active through September 16, 2027.
What is Invenio Imaging Inc.'s most recent federal award?
Invenio Imaging Inc.'s most recent federal grant award is A multicenter study in bronchoscopy combining stimulated raman histology with artificial intelligence for rapid lung… (R44CA281581), from National Cancer Institute (NIH), on March 1, 2023.
On GovTribe
See Invenio Imaging Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors